Skip to content

Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening

Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00585715
Acronym
IH062905
Enrollment
22
Registered
2008-01-03
Start date
2006-10-31
Completion date
2010-01-31
Last updated
2022-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Localized Lipodystrophy

Keywords

Cellulite, Nd:YAG Laser

Brief summary

The purpose of this research study is to evaluate effectiveness of a non-ablative (does not remove skin) treatment for cellulite (dimpled fat) in conjunction with skin tightening using the Candela GentleYAG laser.

Detailed description

The objective of this investigation is to evaluate the effectiveness of a non-ablative treatment for skin laxity by increasing dermatofibrosis of the reticular dermis using the Candela GentleYAG laser. Treatment areas will be limited to the thighs. * The primary objective is to assess the safety and efficacy of the laser for improvement in appearance of cellulite. * The secondary objective is to assess the safety and efficacy of the laser with cooling and the laser without cooling for improvement in appearance of cellulite. This is an open label trial. Treatment will be conducted on either the left or the right thigh, which will be randomly determined. The contra-lateral side will not be treated and will serve as a control. A comparison of baseline photographs (prior to treatments) to photographs taken 1 and 3 months after the completion of treatments will be conducted. Photographic equipment and the protocol for photography will be consistent at each visit. Ultrasound may be taken at baseline and at the follow-up visits to evaluate flatness of cellulite and dermal fibrosis or enlargement of the reticular dermis. The circumference of the area to be treated will be measured with a tape measure, weight/height will be recorded and the Body Mass Index (BMI) will be calculated at baseline and follow-up visits. In addition, skin elasticity may be measured at the treatment areas at baseline and follow-up visits. The photographs, ultrasound and measurements will be taken using consistent procedures at each visit by viewing the baseline photograph and using landmarks such as freckles and birthmarks.

Interventions

3 treatments at 3-5 week intervals Spot size: 10 - 18 mm diameter Fluence: 50 J/cm2 Laser pulse duration: 50 ms Rep. rate: Up to 2 Hz DCD cooling 0-50 ms

Sponsors

Candela Corporation
CollaboratorINDUSTRY
University of California, Irvine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Individuals, male or female, greater than 40 years of age. 2. Moderate skin laxity in the arms, legs, abdomen, or neck. 3. Subject is not overweight. Body Mass Index (B.M.I.) is ≤ 27. 4. Subject has Fitzpatrick skin phototype I-IV. 5. Subject is willing to participate in study and adhere to follow-up schedule. 6. Subject is able to read and comprehend English. 7. Subject has completed Informed Consent Form.

Exclusion criteria

1. Subjects that have had liposuction or other surgical procedures (including mesotherapy) to remove fat in the treatment area during the past year. 2. Subject is overweight (BMI \> 27). 3. Subject has known photosensitivity or history of ingesting medications known to induce photosensitivity in the previous 3 months. 4. Subject has a personal or family history of keloid formation or scarring. 5. Subject is pregnant or lactating. 6. Subject has a history of uncontrolled diabetes and/or requires medication which may interfere with the study. 7. Subjects with a known history of neuropathy. 8. Subjects with a known history of a coagulopathy. 9. Subject is unable or unwilling to comply with the study requirements 10. Subject has pacemaker or metallic implants. 11. Subject has Fitzpatrick skin type V and VI. 12. Subject is mentally incompetent or a prisoner.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Mild to Moderate Reduction in Cellulite.6 month follow upNurnberger-Muller Scale : Stage 0: No dimpling. Stage 1: No dimpling. Stage 2: Dimpling spontaneously standing. Stage 3: Dimpling spontaneously standing and lying down. Texture Scale: Hard or Solid: Pinch test firm folds and furrows. Adherent to deep planes. Not modified with lying versus standing position. Soft or Flaccid: Pinch test spongy and floating folds and furrows. No adherence to deep planes. Not painful, flaccid. Orange peel skin appears spontaneously. Edematous: Doughy consistency. Pain and cramps. Signs of venous and lymphatic insufficiency legs in boot/column. At the 6month follow-up, a blinded assessor ranked changes in cellulite appearance on subject's thighs according to the prior cellulite dimpling and texture criteria. Change in cellulite appearance was assessed on a scale of 0-3, with 0 as no change and 3 as significant change. Improvement in cellulite appearance was characterized by an increase of one unit or more on this scale.
Average Extent of Reduction in Cellulite Appearance for Patients With Reported Mild to Moderate Cellulite Reduction.6 month follow upAt the 6 month follow-up, a blinded assessor ranked change in cellulite appearance on subject's thighs according to the prior cellulite dimpling and texture criteria. Change in cellulite appearance was assessed on a scale of 0-3, with 0 as no change and 3 as significant change. Using this scale, the average reduction in cellulite appearance was calculated for each participant that experienced a mild to moderate reduction in cellulite appearance.

Countries

United States

Participant flow

Participants by arm

ArmCount
Laser With Cooling
Laser used with Candela DCD cooling which produces spray of cryogenic fluid that cools the epidermis prior to each laser pulse. Pulse duration 20-50ms using wavelength 1064nm. Laser treatments repeated every 3 weeks for a total of 3 treatments.
11
Laser Without Cooling
Laser used without Candela DCD cooling. Pulse duration 20-50ms using wavelength 1064nm. Laser treatments repeated every 3 weeks for a total of 3 treatments.
11
Total22

Baseline characteristics

CharacteristicLaser Without CoolingLaser With CoolingTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
11 Participants11 Participants22 Participants
Age, Continuous36 years
STANDARD_DEVIATION 8.40346249
38 years
STANDARD_DEVIATION 9.47724547
37 years
STANDARD_DEVIATION 8.77225062
Region of Enrollment
United States
11 participants11 participants22 participants
Sex: Female, Male
Female
11 Participants11 Participants22 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 80 / 11
serious
Total, serious adverse events
0 / 80 / 11

Outcome results

Primary

Average Extent of Reduction in Cellulite Appearance for Patients With Reported Mild to Moderate Cellulite Reduction.

At the 6 month follow-up, a blinded assessor ranked change in cellulite appearance on subject's thighs according to the prior cellulite dimpling and texture criteria. Change in cellulite appearance was assessed on a scale of 0-3, with 0 as no change and 3 as significant change. Using this scale, the average reduction in cellulite appearance was calculated for each participant that experienced a mild to moderate reduction in cellulite appearance.

Time frame: 6 month follow up

Population: The average amount of cellulite reduction was calculated from the 5 subjects who experienced mild to moderate improvement in cellulite appearance.

ArmMeasureValue (MEAN)Dispersion
Laser With Cooling for Skin TighteningAverage Extent of Reduction in Cellulite Appearance for Patients With Reported Mild to Moderate Cellulite Reduction.1 units on a scaleStandard Deviation 0
Laser Without Cooling for Skin TighteningAverage Extent of Reduction in Cellulite Appearance for Patients With Reported Mild to Moderate Cellulite Reduction.2 units on a scaleStandard Deviation 0
Primary

Number of Participants With Mild to Moderate Reduction in Cellulite.

Nurnberger-Muller Scale : Stage 0: No dimpling. Stage 1: No dimpling. Stage 2: Dimpling spontaneously standing. Stage 3: Dimpling spontaneously standing and lying down. Texture Scale: Hard or Solid: Pinch test firm folds and furrows. Adherent to deep planes. Not modified with lying versus standing position. Soft or Flaccid: Pinch test spongy and floating folds and furrows. No adherence to deep planes. Not painful, flaccid. Orange peel skin appears spontaneously. Edematous: Doughy consistency. Pain and cramps. Signs of venous and lymphatic insufficiency legs in boot/column. At the 6month follow-up, a blinded assessor ranked changes in cellulite appearance on subject's thighs according to the prior cellulite dimpling and texture criteria. Change in cellulite appearance was assessed on a scale of 0-3, with 0 as no change and 3 as significant change. Improvement in cellulite appearance was characterized by an increase of one unit or more on this scale.

Time frame: 6 month follow up

Population: Only subjects who completed the 6 month follow-up were included in the analysis

ArmMeasureValue (NUMBER)
Laser With Cooling for Skin TighteningNumber of Participants With Mild to Moderate Reduction in Cellulite.3 participants
Laser Without Cooling for Skin TighteningNumber of Participants With Mild to Moderate Reduction in Cellulite.2 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026